Astellas Pharma’s Post

One Week Left to Submit Your Applications for the Pitch Event for Investor Day Japan.  Calling life science innovators and entrepreneurs. We’re excited to announce that on March 19 Astellas, BioLabs Global (U.S.), the Innovation Center of Nanomedicine (iCONM) in collaboration with BioLabs and Life Science Innovation Network Japan (LINK-J) will co-host #InvestorDayJapan2026.     The Investor Day Japan 2026 pitch event will bring together the BioLabs community in Japan with the global BioLabs network to provide a platform for early- to mid-stage drug discovery startups to share their stories with investors and industry experts, providing participating entrepreneurs with the opportunity to network with their peers, seize new business opportunities and accelerate the growth of their drug discovery ventures.    We welcome submissions from around the globe – you do not need to be based in Japan to take part. We are accepting pitch applications through December 5. Visit the event website to learn more about eligibility criteria, the pitch submission process and how to attend the pitch event in person.  https://lnkd.in/gDMXFexa #StartupPitch #PioneeringScience

To view or add a comment, sign in

Explore content categories